In women with BRCA1/2 mutations, the use of menopausal hormone therapy does not increase the risk of breast cancer, according to research published in the Journal of the National Cancer Institute.
Because of their high risk…
Hormone Therapy Does Not Increase Breast Cancer Risk in BRCA1/2 Carriers Who Undergo Oophorectomy
